A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Public ClinicalTrials.gov record NCT07233239. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Cannabidiol oral solution (CBD-OS) is approved in the US for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or Tuberous sclerosis complex (TSC) in patients 1 year of age and older. This study will assess the efficacy and safety of CBD-OS in participants aged 12 to 75 years for the treatment of focal-onset seizures (FOS).
Study identification
- NCT ID
- NCT07233239
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 25, 2025
- Primary completion
- Nov 28, 2027
- Completion
- Nov 28, 2027
- Last update posted
- Aug 10, 2026
2025 – 2027
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University Medical Center-Phoenix | Phoenix | Arizona | 85006 | Not yet recruiting |
| UC San Diego | La Jolla | California | 92037-1300 | Recruiting |
| Yale University | New Haven | Connecticut | 06510 | Recruiting |
| University of South Florida | Tampa | Florida | 33606 | Recruiting |
| Emory University | Atlanta | Georgia | 30329 | Recruiting |
| Savannah Neurology Specialists | Savannah | Georgia | 31406 | Recruiting |
| Northwestern University | Chicago | Illinois | 60611 | Recruiting |
| Mid-Atlantic Epilepsy and Sleep Center | Bethesda | Maryland | 20817 | Recruiting |
| Wayne State University | Detroit | Michigan | 48201 | Recruiting |
| Corewell Health | Grand Rapids | Michigan | 49503 | Not yet recruiting |
| Hackensack Meridian Neuroscience Institute at JFK University Medical Center | Edison | New Jersey | 08820 | Not yet recruiting |
| Saint Peter's University Hospital | New Brunswick | New Jersey | 08901 | Recruiting |
| Boston Children's Health Physicians | Hawthorne | New York | 10532 | Recruiting |
| Onsite Clinical Solutions | Charlotte | North Carolina | 28211 | Recruiting |
| Velocity Clinical Research at Raleigh Neurology | Raleigh | North Carolina | 27607 | Recruiting |
| Cincinnati Children's Hospital | Cincinnati | Ohio | 45229 | Recruiting |
| University of Cincinnati, Gardner Neuroscience Institute | Cincinnati | Ohio | 45267-0525 | Recruiting |
| Oregon Health & Science University | Portland | Oregon | 97239 | Recruiting |
| Le Bonheur Children's Hospital | Memphis | Tennessee | 38103 | Recruiting |
| Child Neurology & Consultants of Austin | Austin | Texas | 78757 | Recruiting |
| ANESC Research | El Paso | Texas | 79912 | Recruiting |
| Intermountain Health | Murray | Utah | 84107 | Recruiting |
| Seattle Children's Hospital | Seattle | Washington | 98105 | Recruiting |
| William S Middleton Memorial Veterans Hospital | Madison | Wisconsin | 53705 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07233239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2026 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07233239 live on ClinicalTrials.gov.